Citations for
1FGF8, FGFR3
FGF8 and FGFR3 are up-regulated in hypertrophic chondrocytes: Association with chondrocyte death in deep zone of Kashin-Beck disease.
Liu H, Fang Q, Wang M, Wang W, Zhang M, Zhang D, He Y, Zhang Y, Wang H, Otero M, Ma T, Chen J.
Biochem Biophys Res Commun 500(2):184-190. doi: 10.1016/j.bbrc.2018.04.023. Epub 2018 Apr 17. 2018
2FENS, FGFR3
Fibroblast Growth Factor Receptor 3 Epidermal Naevus Syndrome with Urothelial Mosaicism for the Activating p.Ser249Cys FGFR3 Mutation.
Bessis D, Plaisancié J, Gaston V, Bieth E.
Acta Derm Venereol 97(3):402-403. doi: 10.2340/00015555-2554. 2017
3FGFR3, FGFR4
FGF receptors control alveolar elastogenesis.
Li R, Herriges JC, Chen L, Mecham RP, Sun X.
Development 144(24):4563-4572. doi: 10.1242/dev.149443. Epub 2017 Nov 9. 2017
4ACH, FGFR3
Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
Sarabipour S, Hristova K.
Biochim Biophys Acta 1858(7 Pt A):1436-42. doi: 10.1016/j.bbamem.2016.03.027. Epub 2016 Mar 31. 2016
5BGN, FGF1, FGFR3
Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis.
Winge SB, Nielsen J, Jørgensen A, Owczarek S, Ewen KA, Nielsen JE, Juul A, Berezin V, Rajpert-De Meyts E.
Mol Cell Endocrinol 399:235-43. doi: 10.1016/j.mce.2014.09.018. Epub 2014 Sep 23. 2015
6FGFR3
Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.
Zhou L, Yao LT, Liang ZY, Zhou WX, You L, Shao QQ, Huang S, Guo JC, Zhao YP.
Int J Clin Exp Pathol 8(11):14640-8. eCollection 2015 Nov 1. 2015
7FGFR3
FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
Zhou S, Xie Y, Tang J, Huang J, Huang Q, Xu W, Wang Z, Luo F, Wang Q, Chen H, Du X, Shen Y, Chen D, Chen L.
PLoS Genet 11(6):e1005214. doi: 10.1371/journal.pgen.1005214. eCollection 2015 Jun 19. 2015
8FGFR3
A novel variant of FGFR3 causes proportionate short stature.
Kant SG, Cervenkova I, Balek L, Trantirek L, Santen GW, de Vries MC, van Duyvenvoorde HA, van der Wielen MJ, Verkerk AJ, Uitterlinden AG, Hannema SE, Wit JM, Oostdijk W, Krejci P, Losekoot M.
Eur J Endocrinol 172(6):763-70. doi: 10.1530/EJE-14-0945. Epub 2015 Mar 16. 2015
9FGFR3, PTPN1, PTPN2
Differential regulation of FGFR3 by PTPN1 and PTPN2.
St-Germain JR, Taylor P, Zhang W, Li Z, Ketela T, Moffat J, Neel BG, Trudel S, Moran MF.
Proteomics 15(2-3):419-33. doi: 10.1002/pmic.201400259. Epub 2014 Dec 17. 2015
10BMPR1A, FGFR3, SMURF1
FGFR3 induces degradation of BMP type I receptor to regulate skeletal development.
Qi H, Jin M, Duan Y, Du X, Zhang Y, Ren F, Wang Y, Tian Q, Wang X, Wang Q, Zhu Y, Xie Y, Liu C, Cao X, Mishina Y, Chen D, Deng CX, Chang Z, Chen L.
Biochim Biophys Acta 1843(7):1237-47. doi: 10.1016/j.bbamcr.2014.03.011. Epub 2014 Mar 20. 2014
11FGFR3
The paradox of FGFR3 signaling in skeletal dysplasia: why chondrocytes growth arrest while other cells over proliferate.
Krejci P.
Mutat Res Rev Mutat Res 759:40-8. doi: 10.1016/j.mrrev.2013.11.001. Epub 2013 Dec 1. Review. 2014
12BAIAP2L1, FGFR3
Oncogenic FGFR3 gene fusions in bladder cancer.
Williams SV, Hurst CD, Knowles MA.
Hum Mol Genet 22(4):795-803. doi: 10.1093/hmg/dds486. Epub 2012 Nov 21. 2013
13FGFR1, FGFR3
Fibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting.
Cheng T, Roth B, Choi W, Black PC, Dinney C, McConkey DJ.
PLoS One 8(2):e57284. doi: 10.1371/journal.pone.0057284. Epub 2013 Feb 26. 2013
14FGF23, FGFR3, KL
FGF23 suppresses chondrocyte proliferation in the presence of soluble α-Klotho both in vitro and in vivo.
Kawai M, Kinoshita S, Kimoto A, Hasegawa Y, Miyagawa K, Yamazaki M, Ohata Y, Ozono K, Michigami T.
J Biol Chem 288(4):2414-27. doi: 10.1074/jbc.M112.410043. Epub 2012 Dec 12. 2013
15FGFR3
Structure of FGFR3 transmembrane domain dimer: implications for signaling and human pathologies.
Bocharov EV, Lesovoy DM, Goncharuk SA, Goncharuk MV, Hristova K, Arseniev AS.
Structure 21(11):2087-93. doi: 10.1016/j.str.2013.08.026. Epub 2013 Oct 10. 2013
16FGFR3
The pathogenic A391E mutation in FGFR3 induces a structural change in the transmembrane domain dimer.
Mudumbi KC, Julius A, Herrmann J, Li E.
J Membr Biol 246(6):487-93. doi: 10.1007/s00232-013-9563-6. Epub 2013 Jun 1. 2013
17ACH, FGFR3
Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia.
Lorget F, Kaci N, Peng J, Benoist-Lasselin C, Mugniery E, Oppeneer T, Wendt DJ, Bell SM, Bullens S, Bunting S, Tsuruda LS, O'Neill CA, Di Rocco F, Munnich A, Legeai-Mallet L.
Am J Hum Genet 91(6):1108-14. doi: 10.1016/j.ajhg.2012.10.014. Epub 2012 Nov 29. 2012
18FGFR3
Fibroblast growth factor receptor 3 regulates microtubule formation and cell surface mechanical properties in the developing organ of Corti.
Szarama KB, Stepanyan R, Petralia RS, Gavara N, Frolenkov GI, Kelley MW, Chadwick RS.
Bioarchitecture 2(6):214-9. doi: 10.4161/bioa.22332. 2012
19FGFR3, SCD, SREBF1
FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X, Wang QR, Chan E, Merchant M, Liu J, French D, Ashkenazi A, Qing J.
Cancer Res 72(22):5843-55. doi: 10.1158/0008-5472.CAN-12-1329. Epub 2012 Sep 26. 2012
20FGFR3, HCH
New proposed clinico-radiologic and molecular criteria in hypochondroplasia: FGFR 3 gene mutations are not the only cause of hypochondroplasia.
Song SH, Balce GC, Agashe MV, Lee H, Hong SJ, Park YE, Kim SG, Song HR.
Am J Med Genet A 158A(10):2456-62. doi: 10.1002/ajmg.a.35564. Epub 2012 Aug 17. 2012
21FGFR3
Fibroblast growth factor receptor 3 is highly expressed in rarely dividing human type A spermatogonia.
von Kopylow K, Staege H, Schulze W, Will H, Kirchhoff C.
Histochem Cell Biol 138(5):759-72. doi: 10.1007/s00418-012-0991-7. Epub 2012 Jul 10. 2012
22FGFR3
An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth.
Mugniery E, Dacquin R, Marty C, Benoist-Lasselin C, de Vernejoul MC, Jurdic P, Munnich A, Geoffroy V, Legeai-Mallet L.
Hum Mol Genet 21(11):2503-13. doi: 10.1093/hmg/dds065. Epub 2012 Feb 24. 2012
23FGFR3
A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Jonquoy A, Mugniery E, Benoist-Lasselin C, Kaci N, Le Corre L, Barbault F, Girard AL, Le Merrer Y, Busca P, Schibler L, Munnich A, Legeai-Mallet L.
Hum Mol Genet 21(4):841-51. doi: 10.1093/hmg/ddr514. Epub 2011 Nov 9. 2012
24FGF21, FGFR1, FGFR3, MAPK3
Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate.
Wu S, Levenson A, Kharitonenkov A, De Luca F.
J Biol Chem 287(31):26060-7. doi: 10.1074/jbc.M112.343707. Epub 2012 Jun 13. 2012
25FGFR1, FGFR3, TACC1, TACC3
Transforming fusions of FGFR and TACC genes in human glioblastoma.
Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, Qiu K, Gao Z, Ceccarelli M, Riccardi R, Brat DJ, Guha A, Aldape K, Golfinos JG, Zagzag D, Mikkelsen T, Finocchiaro G, Lasorella A, Rabadan R, Iavarone A.
Science 337(6099):1231-5. doi: 10.1126/science.1220834. 2012
26FGFR3
A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.
Jin M, Yu Y, Qi H, Xie Y, Su N, Wang X, Tan Q, Luo F, Zhu Y, Wang Q, Du X, Xian CJ, Liu P, Huang H, Shen Y, Deng CX, Chen D, Chen L.
Hum Mol Genet 21(26):5443-55. doi: 10.1093/hmg/dds390. Epub 2012 Sep 26. 2012
27FGFR3, SHOX
FGFR3 is a target of the homeobox transcription factor SHOX in limb development.
Decker E, Durand C, Bender S, Rödelsperger C, Glaser A, Hecht J, Schneider KU, Rappold G.
Hum Mol Genet 20(8):1524-35. Epub 2011 Jan 27. 2011
28DEFA5, FGFR3, TCF4
Fibroblast growth factor receptor-3 (FGFR-3) regulates expression of paneth cell lineage-specific genes in intestinal epithelial cells through both TCF4/beta-catenin-dependent and -independent signaling pathways.
Brodrick B, Vidrich A, Porter E, Bradley L, Buzan JM, Cohn SM.
J Biol Chem 286(21):18515-25. Epub 2011 Mar 9. 2011
29CDC37, FGFR3
Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: implications for therapeutic manipulation.
Laederich MB, Degnin CR, Lunstrum GP, Holden P, Horton WA.
J Biol Chem 286(22):19597-604. Epub 2011 Apr 12. 2011
30FGFR1, FGFR2, FGFR3
Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain.
Furusho M, Kaga Y, Ishii A, Hébert JM, Bansal R.
J Neurosci 31(13):5055-66. doi: 10.1523/JNEUROSCI.4800-10.2011. 2011
31FGF18, FGFR3, GLG1
Retention in the Golgi apparatus and expression on the cell surface of Cfr/Esl-1/Glg-1/MG-160 are regulated by two distinct mechanisms.
Miyaoka Y, Kato H, Ebato K, Saito S, Miyata N, Imamura T, Miyajima A.
Biochem J 440(1):33-41. doi: 10.1042/BJ20110318. 2011
32FGFR3, SADDAN
SADDAN syndrome.
Kumar KV, Shaikh A, Sharma R, Prusty P.
J Pediatr Endocrinol Metab 24(9-10):851-2. 2011
33FGFR3
The physical basis of FGFR3 response to fgf1 and fgf2.
Chen F, Hristova K.
Biochemistry 50(40):8576-82. doi: 10.1021/bi200986f. Epub 2011 Sep 16. 2011
34FGFR3
Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3.
Degnin CR, Laederich MB, Horton WA.
Mol Biol Cell 22(20):3861-73. doi: 10.1091/mbc.E11-01-0080. Epub 2011 Aug 24. 2011
35FGFR1, FGFR3
Clathrin- and dynamin-independent endocytosis of FGFR3--implications for signalling.
Haugsten EM, Zakrzewska M, Brech A, Pust S, Olsnes S, Sandvig K, Wesche J.
PLoS One 6(7):e21708. doi: 10.1371/journal.pone.0021708. Epub 2011 Jul 14. 2011
36FGFR3
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
Kiemeney LA, Sulem P, Besenbacher S, Vermeulen SH, Sigurdsson A, Thorleifsson G, Gudbjartsson DF, Stacey SN, Gudmundsson J, Zanon C, Kostic J, Masson G, Bjarnason H, Palsson ST, Skarphedinsson OB, Gudjonsson SA, Witjes JA, Grotenhuis AJ, Verhaegh GW, Bishop DT, Sak SC, Choudhury A, Elliott F, Barrett JH, Hurst CD, de Verdier PJ, Ryk C, Rudnai P, Gurzau E, Koppova K, Vineis P, Polidoro S, Guarrera S, Sacerdote C, Campagna M, Placidi D, Arici C, Zeegers MP, Kellen E, Gutierrez BS, Sanz-Velez JI, Sanchez-Zalabardo M, Valdivia G, Garcia-Prats MD, Hengstler JG, Blaszkewicz M, Dietrich H, Ophoff RA, van den Berg LH, Alexiusdottir K, Kristjansson K, Geirsson G, Nikulasson S, Petursdottir V, Kong A, Thorgeirsson T, Mungan NA, Lindblom A, van Es MA, Porru S, Buntinx F, Golka K, Mayordomo JI, Kumar R, Matullo G, Steineck G, Kiltie AE, Aben KK, Jonsson E, Thorsteinsdottir U, Knowles MA, Rafnar T, Stefansson K.
Nat Genet 42(5):415-9. Epub 2010 Mar 28.PMID: 20348956 2010
37DEL11QD, DEL7P21, DEL9P, DUP5Q35, FGFR2, FGFR3, MSX2, TWIST
Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis.
Wilkie AO, Byren JC, Hurst JA, Jayamohan J, Johnson D, Knight SJ, Lester T, Richards PG, Twigg SR, Wall SA.
Pediatrics 126(2):e391-400. Epub 2010 Jul 19.PMID: 20643727 2010
38ACH, FGFR3
Physical basis behind achondroplasia, the most common form of human dwarfism.
He L, Horton W, Hristova K.
J Biol Chem 285(39):30103-14. Epub 2010 Jul 12. 2010
39ACH, FGFR3, TNTP1, TNTP2
FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
Matsushita T, Wilcox WR, Chan YY, Kawanami A, B�k�lmez H, Balmes G, Krejci P, Mekikian PB, Otani K, Yamaura I, Warman ML, Givol D, Murakami S.
Hum Mol Genet 18(2):227-40. Epub 2008 Oct 15. 2009
40FGFR3
Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in Portugal.
Almeida MR, Campos-Xavier AB, Medeira A, Cordeiro I, Sousa AB, Lima M, Soares G, Rocha M, Saraiva J, Ramos L, Sousa S, Marcelino JP, Correia A, Santos HG.
Clin Genet 75(2):150-6. 2009
41FGFR3, RPS6KA3
Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
Kang S, Elf S, Dong S, Hitosugi T, Lythgoe K, Guo A, Ruan H, Lonial S, Khoury HJ, Williams IR, Lee BH, Roesel JL, Karsenty G, Hanauer A, Taunton J, Boggon TJ, Gu TL, Chen J.
Mol Cell Biol 29(8):2105-17. Epub 2009 Feb 17. 2009
42FGFR3, TNTP1, TNTP2
Thanatophoric dysplasia caused by double missense FGFR3 mutations.
Pannier S, Martinovic J, Heuertz S, Delezoide AL, Munnich A, Schibler L, Serre V, Legeai-Mallet L.
Am J Med Genet A 149A(6):1296-301. 2009
43FGFR3, SPRY4
Cell adaptation to activated FGFR3 includes Sprouty4 up regulation to inhibit the receptor-mediated ERKs activation from the endoplasmic reticulum.
Lievens PM, Zanolli E, Garofalo S, Liboi E.
FEBS Lett 583(19):3254-8. Epub 2009 Sep 15.PMID: 19761767 2009
44FGFR3, HRAS
Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.
Goriely A, Hansen RM, Taylor IB, Olesen IA, Jacobsen GK, McGowan SJ, Pfeifer SP, McVean GA, Meyts ER, Wilkie AO.
Nat Genet 41(11):1247-52. Epub 2009 Oct 25.PMID: 19855393 2009
45FGFR3
Novel FGFR3 mutations in exon 7 and implications for expanded screening of achondroplasia and hypochondroplasia: a response to Heuertz et al.
Friez MJ, Wilson JA.
Eur J Hum Genet 16(3):277-8. Epub 2007 Sep 26. No abstract available. 2008
46FENS, FGFR3
An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation.
García-Vargas A, Hafner C, Pérez-Rodríguez AG, Rodríguez-Rojas LX, González-Esqueda P, Stoehr R, Hernández-Torres M, Happle R.
Am J Med Genet A 146A(17):2275-9. 2008
47FGFR3, SADDAN
Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation.
Zankl A, Elakis G, Susman RD, Inglis G, Gardener G, Buckley MF, Roscioli T.
Am J Med Genet A 146A(2):212-8. 2008
48EFNB1, FGFR1, FGFR2, FGFR3, MSX2, RAB23, TWIST1
Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations.
Passos-Bueno MR, Serti Eacute AE, Jehee FS, Fanganiello R, Yeh E.
Front Oral Biol 12:107-43. Review. 2008
49ARHGEF17, DENN2D, FGFR3
Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.
Bloethner S, Mould A, Stark M, Hayward NK.
Genes Chromosomes Cancer 47(12):1076-85. 2008
50FGF23, FGFR3, FGFR4
FGFR3 and FGFR4 do not mediate renal effects of FGF23.
Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD.
J Am Soc Nephrol 19(12):2342-50. Epub 2008 Aug 27.PMID: 18753255 2008
51FGF18, FGFR3
FGFR3 contributes to intestinal crypt cell growth arrest.
Arnaud-Dabernat S, Yadav D, Sarvetnick N.
J Cell Physiol 216(1):261-8.PMID: 18286540 2008
52FGFR3
Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3.
Eswarakumar VP, Schlessinger J.
Proc Natl Acad Sci U S A 104(10):3937-42. Epub 2007 Feb 23. 2007
53FGFR3, PIK3CA
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.
Hafner C, Lopez-Knowles E, Luis NM, Toll A, Baselga E, Fernandez-Casado A, Hernandez S, Ribe A, Mentzel T, Stoehr R, Hofstaedter F, Landthaler M, Vogt T, Pujol RM, Hartmann A, Real FX.
Proc Natl Acad Sci U S A 104(33):13450-4. Epub 2007 Aug 2. 2007
54FENS, FGFR3, HCH
Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.
Leroy JG, Nuytinck L, Lambert J, Naeyaert JM, Mortier GR.
Am J Med Genet A 143(24):3144-9. 2007
55FGFR3, CRS10
Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature.
Doherty ES, Lacbawan F, Hadley DW, Brewer C, Zalewski C, Kim HJ, Solomon B, Rosenbaum K, Domingo DL, Hart TC, Brooks BP, Immken L, Lowry RB, Kimonis V, Shanske AL, Jehee FS, Bueno MR, Knightly C, McDonald-McGinn D, Zackai EH, Muenke M.
Am J Med Genet A 143(24):3204-15. 2007
56FGFR3
FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation.
Gibbs L, Legeai-Mallet L.
Biochim Biophys Acta 1773(4):502-12. Epub 2007 Jan 20. 2007
57FGFR3
Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.
Hernández S, Toll A, Baselga E, Ribé A, Azua-Romeo J, Pujol RM, Real FX.
J Invest Dermatol 127(7):1664-6. Epub 2007 Jan 25. Review. 2007
58FGFR3
FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization.
Hafner C, Hartmann A, van Oers JM, Stoehr R, Zwarthoff EC, Hofstaedter F, Landthaler M, Vogt T.
Mod Pathol 20(8):895-903. Epub 2007 Jun 22. 2007
59FGFR3, SNAI1
Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias.
de Frutos CA, Vega S, Manzanares M, Flores JM, Huertas H, Martínez-Frías ML, Nieto MA.
Dev Cell 13(6):872-83.PMID: 18061568 2007
60FGFR2, FGFR3, FGF10, LADD1, LADD2, LADD3
Mutations in different components of FGF signaling in LADD syndrome.
Rohmann E, Brunner HG, Kayserili H, Uyguner O, Nurnberg G, Lew ED, Dobbie A, Eswarakumar VP, Uzumcu A, Ulubil-Emeroglu M, Leroy JG, Li Y, Becker C, Lehnerdt K, Cremers CW, Yuksel-Apak M, Nurnberg P, Kubisch C, Schlessinger J, van Bokhoven H, Wollnik B.
Nat Genet 38(4):414-7. Epub 2006 Feb 26. 2006
61LADD1, FGFR2, LADD2, FGFR3, LADD3, FGF10
Still more from FGFR: LADD syndrome caused by different mutations in FGFR and their ligands.
Timmerman M.
Clin Genet 70(1):17-9. No abstract available. 2006
62FGFR3, CATSHL
A Novel Mutation in FGFR3 Causes Camptodactyly, Tall Stature, and Hearing Loss (CATSHL) Syndrome.
Toydemir RM, Brassington AE, Bayrak-Toydemir P, Krakowiak PA, Jorde LB, Whitby FG, Longo N, Viskochil DH, Carey JC, Bamshad MJ.
Am J Hum Genet 79(5):935-941. Epub 2006 Sep 26. 2006
63FGFR3, ACH, HCH
Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.
Heuertz S, Le Merrer M, Zabel B, Wright M, Legeai-Mallet L, Cormier-Daire V, Gibbs L, Bonaventure J.
Eur J Hum Genet 14(12):1240-7. Epub 2006 Aug 16. Erratum in: Eur J Hum Genet. 2006 Dec;14(12):1321. 2006
64FGFR2, FGFR3, TWIST1, EFNB1, CRS, CRS2
Clinical dividends from the molecular genetic diagnosis of craniosynostosis.
Wilkie AO, Bochukova EG, Hansen RM, Taylor IB, Rannan-Eliya SV, Byren JC, Wall SA, Ramos L, Ven‰ncio M, Hurst JA, O'Rourke AW, Williams LJ, Seller A, Lester T.
Am J Med Genet A 140(23):2631-9. Review. 2006
65FGFR3
Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
Lindgren D, Liedberg F, Andersson A, Chebil G, Gudjonsson S, Borg A, MŒnsson W, Fioretos T, Hšglund M.
Oncogene 25(18):2685-96. 2006
66FGFR3, ACH
The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain.
You M, Li E, Hristova K.
Biochemistry 45(17):5551-6. 2006
67FENS, FGFR3
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A.
J Clin Invest 116(8):2201-2207. 2006
68FENS, FGFR3
High frequency of FGFR3 mutations in adenoid seborrheic keratoses.
Hafner C, van Oers JM, Hartmann A, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Vogt T.
J Invest Dermatol 126(11):2404-7. Epub 2006 Jun 15. 2006
69FGF9, FGFR2, FGFR3
Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina.
Cinaroglu A, Ozmen Y, Ozdemir A, Ozcan F, Ergorul C, Cayirlioglu P, Hicks D, Bugra K.
J Neurosci Res 79(3):329-39. 2005
70FGFR3
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Logie A, Dunois-Larde C, Rosty C, Levrel O, Blanche M, Ribeiro A, Gasc JM, Jorcano J, Werner S, Sastre-Garau X, Thiery JP, Radvanyi F.
Hum Mol Genet 14(9):1153-60. Epub 2005 Mar 16. 2005
71MAPK1, MAPK3, TNTP1, TNTP2, FGFR3
Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.
Nowroozi N, Raffioni S, Wang T, Apostol BL, Bradshaw RA, Thompson LM.
Hum Mol Genet 14(11):1529-38. Epub 2005 Apr 20. 2005
72FGFR3, FGF18
Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis.
Davidson D, Blanc A, Filion D, Wang H, Plut P, Pfeffer G, Buschmann MD, Henderson JE.
J Biol Chem 280(21):20509-15. Epub 2005 Mar 21. 2005
73FGFR3
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.
Jebar AH, Hurst CD, Tomlinson DC, Johnston C, Taylor CF, Knowles MA.
Oncogene 24(33):5218-25. 2005
74FGFR3
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies.
Chen J, Lee BH, Williams IR, Kutok JL, Mitsiades CS, Duclos N, Cohen S, Adelsperger J, Okabe R, Coburn A, Moore S, Huntly BJ, Fabbro D, Anderson KC, Griffin JD, Gilliland DG.
Oncogene 24(56):8259-67. 2005
75FGFR3, ACH
Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.
Cho JY, Guo C, Torello M, Lunstrum GP, Iwata T, Deng C, Horton WA.
Proc Natl Acad Sci U S A 101(2):609-14. Epub 2003 Dec 29. 2004
76FGFR1, FGFR3, CRS10, CRS7A
Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity.
Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M.
Hum Mol Genet 13(1):69-78. Epub 2003 Nov 12. 2004
77FGFR3, CRS10
Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.
Rannan-Eliya SV, Taylor IB, De Heer IM, Van Den Ouweland AM, Wall SA, Wilkie AO.
Hum Genet 115(3):200-7. Epub 2004 Jul 07. 2004
78FGFR3, NSD2, TACC3
Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma.
Stewart JP, Thompson A, Santra M, Barlogie B, Lappin TR, Shaughnessy J Jr.
Br J Haematol 126(1):72-6. 2004
79FGFR3, TNTP2
The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum.
Lievens PM, Liboi E.
J Biol Chem 278(19):17344-9. Epub 2003 Mar 06. 2003
80FGFR3
FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.
Sturla LM, Merrick AE, Burchill SA.
Br J Cancer 89(7):1276-84. 2003
81FGFR3
Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells.
Jang JH.
Biochem Biophys Res Commun 292(2):378-82. 2002
82FGFR1, FGFR2, FGFR3, MSX2, TWIST1
Craniosynostosis associated with ocular and distal limb defects is very likely caused by mutations in a gene different from FGFR, TWIST, and MSX2.
Passos-Bueno MR, Armelin LM, Alonso LG, Neustein I, Sertie AL, Abe K, Pavanello Rde C, Elkis LC, Koiffmann CP.
Am J Med Genet 2002
83FGFR3
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
Van Rhijn BW, Van Tilborg AA, Lurkin I, Bonaventure J, De Vries A, Thiery JP, Van Der Kwast TH, Zwarthoff EC, Radvanyi F.
Eur J Hum Genet 10(12):819-24. 2002
84FGFR3
FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance.
Rasmussen T, Hudlebusch HR, Knudsen LM, Johnsen HE.
Br J Haematol 117(3):626-8. 2002
85ACS3, TWIST1, FGFR3
Genetic analysis of patients with the Saethre-Chotzen phenotype.
Chun K, Teebi AS, Jung JH, Kennedy S, Laframboise R, Meschino WS, Nakabayashi K, Scherer SW, Ray PN, Teshima I.
Am J Med Genet 110(2):136-43. 2002
86FGFR3, IHH, PTHLH
A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia.
Chen L, Li C, Qiao W, Xu X, Deng C.
Hum Mol Genet 10(5):457-65. 2001
87BSCGS2, FGFR3
Premature calvarial synostosis and epidermal hyperplasia (Beare-Stevenson syndrome-like anomalies) resulting from a P250R missense mutation in the gene encoding fibroblast growth factor receptor 3.
Roscioli T, Flanagan S, Mortimore RJ, Kumar P, Weedon D, Masel J, Lewandowski R, Hyland V, Glass IA.
Am J Med Genet 101(3):187-94. 2001
88FGFR3
Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.
Sibley K, Cuthbert-Heavens D, Knowles MA.
Oncogene 20(6):686-91. 2001
89FGFR3
A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells.
Shimizu A, Tada K, Shukunami C, Hiraki Y, Kurokawa T, Magane N, Kurokawa-Seo M.
J Biol Chem 276(14):11031-40. 2001
90FGFR3
The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.
Kimura T, Suzuki H, Ohashi T, Asano K, Kiyota H, Eto Y.
Cancer 92(10):2555-61. 2001
91ETV6, FGFR3
Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation.
Yagasaki F, Wakao D, Yokoyama Y, Uchida Y, Murohashi I, Kayano H, Taniwaki M, Matsuda A, Bessho M.
Cancer Res 61(23):8371-4. 2001
92FGFR3
A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.
Iwata T, Chen L, Li C, Ovchinnikov DA, Behringer RR, Francomano CA, Deng CX.
Hum Mol Genet 9(11):1603-13. 2000
93ACH, FGFR3, HCH
Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene.
Mortier G, Nuytinck L, Craen M, Renard JP, Leroy JG, de Paepe A.
J Med Genet 37(3):220-4. No abstract available. 2000
94FGFR3
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.
Bellus GA, Spector EB, Speiser PW, Weaver CA, Garber AT, Bryke CR, Israel J, Rosengren SS, Webster MK, Donoghue DJ, Francomano CA.
Am J Hum Genet 67(6):1411-21. 2000
95FGFR3
Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer.
Jang JH, Shin KH, Park YJ, Lee RJ, McKeehan WL, Park JG.
Cancer Res 60(15):4049-52. 2000
96FGFR3, IGHJ@
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
Avet-Loiseau H, Brigaudeau C, Morineau N, Talmant P, Lai JL, Daviet A, Li JY, Praloran V, Rapp MJ, Harousseau JL, Facon T, Bataille R.
Genes Chromosomes Cancer 24 : 9-15. 1999
97CRS10, FGFR3
Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation.
Lajeunie E, et al.
J Med Genet 36 : 9-13. 1999
98FGFR3, SADDAN
A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.
Tavormina PL, et al.
Am J Hum Genet 64(3):722-31. 1999
99FGFR1, FGFR2, FGFR3
Clinical spectrum of fibroblast growth factor receptor mutations.
Passos-Bueno MR, et al.
Hum Mutat 14(2):115-25. 1999
100FGFR3
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.
Cappellen D, et al.
Nat Genet 23(1):18-20. No abstract available 1999
101FGFR3, SADDAN
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
Bellus GA, et al.
Am J Med Genet 85(1):53-65 1999
102ACS1, ACS3, CRS10, CRS11, DEL7P21, CRS5A, CRS5B, CRS6, CRS7B, CRS8, BSCGS1, CRSCNS, FGFR1, FGFR2, FGFR3, MSX2, SADDAN, TWIST1
Craniosynostosis Syndromes: From Genes to Premature Fusion of Skull Bones.
Hehr U, et al.
Mol Genet Metab 68(2):139-151. No abstract available 1999
103ACH, FGFR3
Comparison of clinical-radiological and molecular findings in hypochondroplasia.
Prinster C, Carrera P, Del Maschio M, Weber G, Maghnie M, Vigone MC, Mora S, Tonini G, Rigon F, Beluffi G, Severi F, Chiumello G, Ferrari M.
Am J Med Genet 75(1):109-12. 1998
104FGFR1, FGFR2, FGFR3
Conserved use of a non-canonical 5' splice site (/GA) in alternative splicing by fibroblast growth factor receptors 1, 2 and 3.
Twigg SRF, et al.
Hum Mol Genet 7 : 685-691. 1998
105CRS10, CRSCNS, FGFR3
Syndrome of coronal craniosynostosis with brachydactyly and carpal/tarsal coalition due to Pro250Arg mutation in FGFR3 gene.
Graham JM, et al.
Am J Med Genet 77 : 322-329. 1998
106ACS3, CRS10, FGFR3, TWIST1
Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations.
Paznekas WA, et al.
Am J Hum Genet 62 : 1370-1380. 1998
107FGFR3, TNTP1
Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia.
Legeai-Mallet L, et al.
J Biol Chem 273 : 13007-13014. 1998
108ACH, FGFR3
Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome.
Wilkin DJ, et al.
Am J Hum Genet 63 : 711-716. 1998
109FGFR3, MSH6, NSD2
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Chesi M, et al.
Blood 92 : 3025-3034. 1998
110CRS10, CRSCNS, FGFR3
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.
Muenke M, et al.
Am J Hum Genet 60 : 555-564. 1997
111CRSCNS, FGFR3
Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis.
Moloney DM, et al.
Lancet 349 : 1059-1062. 1997
112FGFR3
Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene.
Perez-Castro AV, et al.
Genomics 41 : 10-16. 1997
113ACH, FGFR3, TNTP1
Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts.
Nguyen HB, Estacion M, Gargus JJ.
Hum Mol Genet 6(5):681-8. 1997
114FGFR3
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.
Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL.
Nat Genet 16(3):260-4. 1997
115FGFR3
Human fibroblast growth factor receptor 3 gene (FGFR3): genomic sequence and primer set information for gene analysis.
Wuchner C, Hilbert K, Zabel B, Winterpacht A.
Hum Genet 100(2):215-9. 1997
116CRSCNS, FGFR3, CRS10
Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis.
Reardon W, Wilkes D, Rutland P, Pulleyn LJ, Malcolm S, Dean JC, Evans RD, Jones BM, Hayward R, Hall CM, Nevin NC, Baraister M, Winter RM.
J Med Genet 34(8):632-6. 1997
117CRSCNS, FGFR3, CRS10
Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family.
Golla A, Lichmer P, von Gernet S, Winterpacht A, Fairley J, Murken J, Schuffenhauer S.
J Med Genet 34(8):683-4. 1997
118DUP4P16, PRDS1,DUP4P, FGFR3
Translocations involving 4p16.3 in three families: deletion causing the Pitt-Rogers-Danks syndrome and duplication resulting in a new overgrowth syndrome.
Partington MW, Fagan K, Soubjaki V, Turner G.
J Med Genet 34(9):719-28. 1997
119FGFR3, TNTP1
Abnormal FGFR3 expression in cartilage of thanatophoric dysplasia fetuses.
Delezoide AL, Lasselin-Benoist C, Legeai-Mallet L, Brice P, Senee V, Yayon A, Munnich A, Vekemans M, Bonaventure J.
Hum Mol Genet 6(11):1899-906. 1997
120CRSCNS, FGFR3
Identification of the first genetic cause for isolated anterior synostotic plagiocephaly : a unique mutation in the fibroblast growth factor receptor 3. (abstr)
Gripp KW, et al.
Am J Hum Genet 61 : A49. 1997
121FGFR3
A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene.
Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A.
Blood 90(10):4062-70. 1997
122ACH, FGFR3
Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
Webster MK, et al.
EMBO J 15 : 520-527. 1996
123ACH, FGFR3
Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia.
Rousseau F, et al.
Horm Res 45 : 108-110. 1996
124FGFR3
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
Colvin JS, et al.
Nat Genet 12 : 390-397. 1996
125TNTP1, FGFR3
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1).
Rousseau F, et al.
Hum Mol Genet 5 : 509-512. 1996
126FGFR3, ACH
Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
Deng C, et al.
Cell 84 : 911-921. 1996
127ACH, FGFR3
Chinese achondroplasia is also defined by recurrent G380R mutations of the fibroblast growth factor receptor-3 gene.
Niu DM, et al.
Hum Genet 98 : 65-67. 1996
128FGFR3, TNTP1, ACH
Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
Bonaventure J, et al.
Am J Med Genet 63 : 148-154. 1996
129FGFR3, ACH, TNTP1
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
Naski MC, et al.
Nat Genet 13 : 233-237. 1996
130TNTP1, FGFR3
Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II.
Webster MK, et al.
Mol Cell Biol 16 : 4081-4087. 1996
131ACH, FGFR3
Clinical and genetic heterogeneity of hypochondroplasia.
Rousseau F, et al.
J Med Genet 33 : 749-752. 1996
132CRS5B, FGFR3
A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.
Wilkes D, et al.
J Med Genet 33 : 744-748. 1996
133CRS7A, CRS7B, FGFR1, FGFR2, FGFR3
Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.
Bellus GA, et al.
Nat Genet 14 : 174-176. 1996
134FGFR3, TNTP1
Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene.
Pokharel RK, et al.
Biochem Biophys Res Commun 227 : 236-239. 1996
135FGFR3
Achondroplasia is defined by recurrent G380R mutations of FGFR3.
Bellus GA, et al.
Am J Hum Genet 56 : 368-373. 1995
136FGFR3, TNTP1
Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type 1.
Tavormina PL, et al.
Hum Mol Genet 4 : 2175-2177. 1995
137FGFR3, ACH
A common FGFR3 gene mutation in hypochondroplasia.
Prinos P, et al.
Hum Mol Genet 4 : 2097-2101. 1995
138FGFR3, ACH
Atypical radiological findings in achondroplasia with uncommon mutation of the fibroblast growth factor receptor-3 (FGFR-3) gene (Gly to Cys transition at codon 375).
Nishimura G, et al.
Am J Med Genet 59 : 393-395. 1995
139CRS5B, FGFR3
Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA, et al.
Nat Genet 11 : 462-464. 1995
140FGFR3, ACH
Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
Tonoki H, et al.
Jpn J Hum Genet 40 : 347-349. 1995
141TNTP1, FGFR3
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
Tavormina PL, et al.
Nat Genet 9 : 321-328. 1995
142FGFR3, TNTP1
Stop codon FGFR3 mutations in thanatophoric dwarfism type 1.
Rousseau F, et al.
Nat Genet 10 : 11-12. 1995
143FGFR3, ACG2
Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japenese patients.
Ikegawa S, et al.
Hum Genet 96 : 309-311. 1995
144ACH, FGFR3
A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia.
Stoilov I, et al.
Am J Med Genet 55 : 127-133. 1995
145FGFR3
The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific.
Scotet E, Houssaint E.
Biochim Biophys Acta 1264(2):238-42. 1995
146ACH, FGFR3, HCH
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA.
Nat Genet 10(3):357-9. 1995
147ACH, FGFR3
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
Shiang R, et al.
Cell 78 : 335-342. 1994
148ACH, FGFR3
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
Rousseau F, et al.
Nature 371 : 252-254. 1994
149FGFR3
Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.
Murgue B, et al.
Cancer Res 54 : 5206-5211. 1994
150FGFR3
Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.
Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM.
J Biol Chem 269(15):11620-7. 1994
151FGFR3
The fibroblast growth factor receptor 3 gene (FGFR3) is assigned to human chromosome 4.
Keegan K, et al.
Cytogenet Cell Genet 62 : 172-175. 1993
152FGFR3
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.
Keegan K, et al.
Proc Natl Acad Sci U S A 88 : 1095-1099. 1991
153FGFR3
A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4.
Thompsom LM, et al.
Genomics 11 : 1133-1142. 1991